𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response

✍ Scribed by Jonsdottir, T.; Zickert, A.; Sundelin, B.; Henriksson, E. W.; van Vollenhoven, R. F.; Gunnarsson, I.


Book ID
121731527
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
225 KB
Volume
52
Category
Article
ISSN
1462-0324

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Histopathologic and clinical outcome of
✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn JΓ³nsdΓ³ttir; Stefan H. Jacobson; Elisa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 106 KB πŸ‘ 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose